The Global Microarrays Market is expected to grow at a CAGR of 7.24% as the demand for drug discovery, disease diagnostics, and precision medicine continues to accelerate.Austin, Texas, Jan. 26, 2026 ...
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026 Twist Bioscience Corporation ...
JA Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. The authors have no other relevant affiliations or financial involvement with any organization or ...
The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, function, and interactions. Proteomics plays a critical role in understanding ...
Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...
With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers. The life sciences tools and services sector ...
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $128.8, ...
New “AI GYM for Science” dramatically boosts the biological and chemical intelligence of any causal or frontier LLM, ...
The approach uses an iteration of the SHERLOCK technology exclusively licensed to OraSure Technologies' subsidiary, Sherlock Biosciences.
JPT is a key player in the world of peptides. They create special tools like peptide microarrays that help map out immune responses. They also offer services that speed up the creation of new ...
Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results